Eledon Pharmaceuticals, Inc.
General ticker "ELDN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $216.6M (TTM average)
Eledon Pharmaceuticals, Inc. does not follow the US Stock Market performance with the rate: -14.3%.
Estimated limits based on current volatility of 3.8%: low 2.51$, high 2.71$
Factors to consider:
- Earnings expected soon, date: 2026-03-19 bmo
- Total employees count: 20 (+17.6%) as of 2023
- Top business risk factors: Substantial doubt about continuing as a going concern, Insufficient funding, Dependence on successful drug development, Operational and conduct risks, Commercialization challenges
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.87$, 6.62$]
- 2025-12-31 to 2026-12-31 estimated range: [2.25$, 5.36$]
Short-term ELDN quotes
Long-term ELDN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $39.78MM | $43.00MM | $70.58MM |
| Operating Income | $-39.78MM | $-43.00MM | $-70.58MM |
| Non-Operating Income | $-48.19MM | $-73.54MM | $34.82MM |
| R&D Expense | $27.08MM | $30.31MM | $51.96MM |
| Income(Loss) | $-87.97MM | $-116.54MM | $-35.75MM |
| Taxes | $0.00MM | $0.00MM | $0.43MM |
| Profit(Loss)* | $-87.97MM | $-116.54MM | $-36.18MM |
| Stockholders Equity | $84.18MM | $7.21MM | $118.14MM |
| Assets | $92.79MM | $89.07MM | $177.41MM |
| Operating Cash Flow | $-28.42MM | $-39.53MM | $-47.27MM |
| Investing Cash Flow | $0.00MM | $-45.29MM | $-70.31MM |
| Financing Cash Flow | $0.00MM | $33.02MM | $133.52MM |
| Earnings Per Share** | $-6.16 | $-4.73 | $-0.75 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.